Hostname: page-component-586b7cd67f-rcrh6 Total loading time: 0 Render date: 2024-11-25T07:45:21.707Z Has data issue: false hasContentIssue false
  • English
  • Français

Lacunar Stroke Associated with Methylphenidate Abuse

Published online by Cambridge University Press:  02 December 2014

Hamid Sadeghian
Hamid Sadeghian*
Affiliation:
Department of Neurology, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background:

Methylphenidate is a central nervous system stimulant used for the treatment of attention deficit hyperactivity disorder and narcolepsy and like other psychostimulants has a potential for abuse.

Case study:

A young man with a cerebral lacunar infarction following chronic oral abuse of methylphenidate is presented.

Conclusion:

The experience of our patient and a review of the literature suggest that cerebral infarction is a potential side effect of chronic consumption of methylphenidate.

Type
Case Report
Information
Canadian Journal of Neurological Sciences , Volume 31 , Issue 1 , February 2004 , pp. 109 - 111
Copyright
Copyright © The Canadian Journal of Neurological 2004

References

1.Challman, TD, Lipsky, JJ.Methylphenidate: its pharmacology and uses. Mayo Clin Proc 2000; 75: 711–721.Google Scholar
2.Jansen, IH, Olde Rikkert, MG, Hulsbos, HA, Hoefnagels, WH.Toward individualized evidence-based medicine: five “N of 1” trials of methylphenidate in geriatric patients. J Am Geriatr Soc 2001; 49: 474–476.CrossRefGoogle ScholarPubMed
3.Johnson, ML, Roberts, MD, Ross, AR, Witten, CM.Methylphenidate in stroke patients with depression. Am J Phys Med Rehabil 1992;71(4): 239–241.CrossRefGoogle ScholarPubMed
4.Glenn, MB.Methylphenidate for cognitive and behavioral dysfunction after traumatic brain injury. J Head Trauma Rehabil 1998; 13: 87–90.CrossRefGoogle ScholarPubMed
5.Rozans, M, Dreisbach, A, Lertora, JJ, Kahn, MJ.Palliative uses of methylphenidate in patients with cancer: a review. J Clin Oncol 2002; 20: 335–339.Google Scholar
6.Hinkin, CH, Castellon, SA, Hardy, DJ, et al.Methylphenidate improves HIV-1-associated cognitive slowing. J Neuropsychiatry Clin Neurosci 2001; 13: 248–254.CrossRefGoogle ScholarPubMed
7.Vastag, B.Pay attention: Ritalin acts much like cocaine. JAMA 2001; 286: 905906.Google ScholarPubMed
8.Meririnne, E, Kankaanpaa, A, Seppala, T.Rewarding properties of methylphenidate: sensitization by prior exposure to the drug and effects of dopamine D1- and D2-receptor antagonists. J Pharmacol Exp Ther 2001; 298: 539–550.Google Scholar
9.Jones, SR, Joseph, JD, Barak, LS, Caron, MG, Wightman, RM.Dopamine neuronal transport kinetics and effects of amphetamine. J Neurochem 1999; 73: 2406–2414.Google Scholar
10.Martinez-Cano, H, Martinez-Gras, I, De Iceta, M, Rodao, JM, Vela Bueno, A.Methylphenidate in stimulants abuse: three case reports. Am J Addict 2001; 10: 192–193.Google Scholar
11. Rappley, MD.Safety issues in the use of methylphenidate. An American perspective. Drug Safety 1997; 17: 143–148.CrossRefGoogle ScholarPubMed
12.Babcock, O, Byrne, T.Student perceptions of methylphenidate abuse at a public liberal arts college. J Am Coll Health 2000; 49: 143–145.CrossRefGoogle Scholar
13.Weiner, AL.Emerging drugs of abuse in Connecticut. Conn Med 2000; 64: 19–23.Google ScholarPubMed
14.Klein-Schwartz, W.Abuse and toxicity of methylphenidate. Curr Opin Pediatr 2002; 14: 219–223.CrossRefGoogle ScholarPubMed
15.Lipkin, PH, Goldstein, IJ, Adesman, AR.Tics and dyskinesias associated with stimulant treatment in attention-deficit hyperactivity disorder. Arch Pediatr Adolesc Med 1994; 148:859–861.CrossRefGoogle ScholarPubMed
16.Parran, TV Jr, Jasinski, DR.Intravenous methylphenidate abuse: prototype for prescription drug abuse. Arch Intern Med 1991;151: 781–783.CrossRefGoogle ScholarPubMed
17.Still, A, Gordon, M, Mercer, J, Roake, J.Ritalin: drug of abuse. Two case reports of intra-arterial injection. N Z Med J 2001; 114: 521–522.Google Scholar
18.Jaffe, SL.Intranasal abuse of prescribed methylphenidate by an alcohol and drug abusing adolescent with ADHD. J Am Acad Child Adolesc Psychiatry 1991; 30: 773–775.Google Scholar
19.Stecyk, O, Loludice, TA, Demeter, S, Jacobs, J.Multiple organ failure resulting from intravenous abuse of methylphenidate hydrochloride. Ann Emerg Med 1985; 14: 597–599.Google Scholar
20.Kishorekumar, R, Yagnik, PDhopesh, V.Acute myelopathy in a drug abuser following an attempted neck vein injection. J Neurol Neurosurg Psychiatry 1985; 48: 843–844.Google Scholar
21.Zemplenyi, J, Colman, MF.Deep neck abscesses secondary to methylphenidate (Ritalin) abuse. Head Neck Surg 1984; 6: 858–860.Google Scholar
22.Sherman, CB, Hudson, LD, Pierson, DJ.Severe precocious emphysema in intravenous methylphenidate (Ritalin) abusers. Chest 1987; 92: 1085–1087.Google Scholar
23.Massello, W 3rd, Carpenter, DA.A fatality due to intranasal abuse of methylphenidate (Ritalin). J Forensic Sci 1999; 44: 220–221.Google Scholar
24.Harrington, H, Heller, HA, Dawson, D, et al.Intracerebral hemorrhage and oral amphetamine. Arch Neurol 1983; 40: 503–507.Google Scholar
25.Brust, JCM.Stroke and substance abuse. In: Barnett, HJM, Mohr, JP, Stein, BM, Yatsu, FM, (Eds). Stroke: pathophysiology, diagnosis, and management. Philadelphia: Churchill Livingstone, 1998:979–1000.Google Scholar
26.Levine, SR, Brust, JCM, Futrell, N, et al.Cerebrovascular complications of the use of the 201C;crack” form of alkaloidal cocaine. N Eng J Med 1990; 323: 699–704.Google Scholar
27.Edwards, M, Russo, L, Harwood-Nuss, A.Cerebral infarction with a single oral dose of phenylpropanolamine. Am J Emerg Med 1987; 5: 163–164.Google Scholar
28.Perez, JA Jr, Arsura, EL, Strategos, S.Methamphetamine-related stroke: four cases. J Emerg Med 1999; 17; 469–471.Google Scholar
29.Hanyu, S, Ikeguchi, K, Imai, H, Imai, N, Yoshida, M.Cerebral infarction associated with 3,4-methylenedioxymethamphetamine (’Ecstasy’) abuse. Eur Neurol 1995; 35:173.Google Scholar
30.Rumbaugh, CL, Fang, HCH, Higgins, RE, et al.Cerebral microvascular injury in experimental drug abuse. Invest Radiol 1976; 11: 282–294.CrossRefGoogle ScholarPubMed
31.Trugman, JM.Cerebral arteritis and oral methylphenidate. Lancet 1988; 1 (8585): 584–585.Google Scholar
32.Schteinschnaider, A, Plaghos, LL, Garbugino, S, et al.Cerebral arteritis following methylphenidate use. J Child Neurol 2000; 15: 265–267.CrossRefGoogle ScholarPubMed